Loading clinical trials...
Loading clinical trials...
A Phase I, Dose Escalation Trial of Endoluminal High Dose Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Conditions
Interventions
endorectal brachytherapy
concurrent capecitabine or 5-FU
+1 more
Locations
7
United States
Memorial Sloan Kettering Basking Ridge (Follow Up Only)
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Follow Up Only)
Middletown, New Jersey, United States
Memorial Sloan Kettering Commack (Consent and Follow up)
Commack, New York, United States
Memorial Sloan Kettering Westchester (Follow Up Only)
Harrison, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Memorial Sloan Kettering Rockville Center (Follow Up Only)
Rockville Centre, New York, United States
Start Date
July 1, 2014
Primary Completion Date
October 29, 2024
Completion Date
October 29, 2024
Last Updated
November 1, 2024
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions